Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Operating Income of -$493.37 million for fiscal year 2025.
INTEGRA LIFESCIENCES HOLDINGS CORP Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$493.37M | -1836.5% |
| 2024 | $28.41M | -74.5% |
| 2023 | $111.53M | -53.3% |
| 2022 | $238.92M | +21.1% |
| 2021 | $197.23M | +30.3% |
| 2020 | $151.37M | +61.4% |
| 2019 | $93.76M | -15.5% |
| 2018 | $111.00M | +147.7% |
| 2017 | $44.80M | -61.2% |
| 2016 | $115.34M | +44.9% |
| 2015 | $79.59M | +17.3% |
| 2014 | $67.86M | +91.8% |
| 2013 | $35.37M | -52.1% |
| 2012 | $73.78M | +34.4% |
| 2011 | $54.91M | -44.4% |
| 2010 | $98.69M | +0.9% |
| 2009 | $97.82M | +106.3% |
| 2008 | $47.41M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.76M | +244.3% | +102.3% |
| June 30, 2025 | -$512.67M | -16825.5% | -3208.2% |
| March 31, 2025 | -$15.50M | -490.9% | -90.1% |
| September 30, 2024 | -$8.15M | -130.6% | -169.1% |
| June 30, 2024 | -$3.03M | -124.2% | -176.4% |
| March 31, 2024 | $3.96M | -89.1% | -85.1% |
| September 30, 2023 | $26.59M | -59.1% | +112.7% |
| June 30, 2023 | $12.50M | -79.1% | -65.6% |
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -1836.5% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, INTEGRA LIFESCIENCES HOLDINGS CORP’s operating income has declined by 1140.6% (from $47.41 million to -$493.37 million).
- The most recent figure is from INTEGRA LIFESCIENCES HOLDINGS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: